"
Team:Wageningen UR/Safety/Nine
From 2011.igem.org
(Difference between revisions)
(→Safety) |
(→Safety) |
||
| Line 30: | Line 30: | ||
| - | Kim M, Shin JH, Suh SP, Ryang DW, Park CS, Kim C, Kook H, Kim J. '''Aspergillus nidulans infection in a patient with chronic granulomatous disease'''. J Korean Med Sci. 1997 Jun;12(3):244-248. URL: http://synapse.koreamed.org/DOIx.php?id=10.3346%2Fjkms.1997.12.3.244. A small fragment was used. Copyright © 1997 The Korean Academy of Medical Sciences. | + | Kim M, Shin JH, Suh SP, Ryang DW, Park CS, Kim C, Kook H, Kim J. '''Aspergillus nidulans infection in a patient with chronic granulomatous disease'''. J Korean Med Sci. 1997 Jun;12(3):244-248. <br />URL: http://synapse.koreamed.org/DOIx.php?id=10.3346%2Fjkms.1997.12.3.244. <br />A small fragment was used. Copyright © 1997 The Korean Academy of Medical Sciences. |
| - | + | <br />[[#Pathogenicity of host organisms|Return]] | |
EPA(U.S. Environmental Protection Agency). (2011, January Monday). Escherichia coli K-12 TSCA Section 5(h)(4) Exemption: Final Decision Document. Retrieved July 2011, from Biotechnology Program under the Toxic Substances Control Act (TSCA): | EPA(U.S. Environmental Protection Agency). (2011, January Monday). Escherichia coli K-12 TSCA Section 5(h)(4) Exemption: Final Decision Document. Retrieved July 2011, from Biotechnology Program under the Toxic Substances Control Act (TSCA): | ||
| - | http://www.epa.gov/biotech_rule/pubs/fra/fd004.htm | + | <br />http://www.epa.gov/biotech_rule/pubs/fra/fd004.htm |
| - | + | <br />[[#Pathogenicity of host organisms|Return]] | |
iGEM. (2011). Safety. Retrieved July 2011, from iGEM 2011: | iGEM. (2011). Safety. Retrieved July 2011, from iGEM 2011: | ||
| - | https://2011.igem.org/Safety | + | <br />https://2011.igem.org/Safety |
| - | + | <br />[[#2. Notification|Return]] | |
Revision as of 09:29, 23 August 2011
